Hexu Qi, Zhenxing Zhao, Zhenxing Zhao, Lin Xu, Yue Zhang, Yifei Li, . . . Jie Fang. (2022). Antisense Oligonucleotide-Based Therapy on miR-181a-5p Alleviates Cartilage Degradation of Temporomandibular Joint Osteoarthritis via Promoting SIRT1. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHexu Qi, et al. Antisense Oligonucleotide-Based Therapy on MiR-181a-5p Alleviates Cartilage Degradation of Temporomandibular Joint Osteoarthritis via Promoting SIRT1. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationHexu Qi, et al. Antisense Oligonucleotide-Based Therapy on MiR-181a-5p Alleviates Cartilage Degradation of Temporomandibular Joint Osteoarthritis via Promoting SIRT1. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.